Harbor, initially an AI-enabled system of record for clinical trial data, has expanded into full-service contract research organization (CRO) capabilities.
With its advanced platform capable of automating and compressing labor-intensive tasks, Harbor supports seven active trials and recently signed a seven-figure contract to execute a full clinical trial for a publicly traded medical device company.
The company addresses the $82 billion CRO market, aiming to provide regulated services with greater efficiency, fewer handoffs, and better margins.
The transition into broader clinical trial services amplifies its market potential and validates its business model. Current monthly software revenue stands at $15.6k, showcasing traction in its SaaS offering.